78
Participants
Start Date
October 20, 2022
Primary Completion Date
October 1, 2024
Study Completion Date
May 1, 2025
Atrial ablation for subject scheduled for a de novo endocardial ablation of symptomatic, drug-refractory PsAF.
Treatment will include the isolation of pulmonary veins (PVIs), and isolation of the left atrial posterior wall (PWI). A right atrial cavo-tricuspid line for bi-directional block may be performed at discretion and clinical judgment of the investigator
RECRUITING
St Antonius Ziekenhuis, Nieuwegein
RECRUITING
Onze-Lieve-Vrouwziekenhuis (OLV), Aalst
RECRUITING
McGill University Health Centre (MUHC), Montreal General Hospital (MGH), Montreal
RECRUITING
Nemocnice Na Homolce, Prague
RECRUITING
Blackrock Health, Dublin
RECRUITING
St George'S University Hospital, London
Lead Sponsor
Adagio Medical
INDUSTRY